Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sacha Howell

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
BMJ Open|April 29, 2026
Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancerLaura Kinsey, David French, Sacha Howell, et al.
Acta Oncologica (Stockholm, Sweden)|August 27, 2025
Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000Hannah Chamberlin, Georgios Ntentas, David J Cutter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Impaired tamoxifen metabolism reduces survival in familial breast cancer patientsWilliam G Newman, Kristen D Hadfield, Ayshe Latif, et al.
Breast (Edinburgh, Scotland)|February 26, 2019
Predictors of weight gain in a cohort of premenopausal early breast cancer patients receiving chemotherapyAshu Gandhi, Ellen Copson, Diana Eccles, et al.
Trials|January 17, 2020
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trialRob Coleman, Janet Brown, Emma Rathbone, et al.
Breast Cancer Research and Treatment|January 29, 2010
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancerRuth E Board, Andrew M Wardley, J Michael Dixon, et al.
British Journal of Cancer|August 2, 2019
The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trialMichelle Harvie, Mary Pegington, Debbie McMullan, et al.
Breast Cancer Research and Treatment|October 27, 2017
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Breast Cancer Research and Treatment|June 15, 2017
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Journal of Bone Oncology|July 8, 2022
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial resultsMatthew Winter, Rob Coleman, Jessica Kendall, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
BMJ Open|April 29, 2026
Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancerLaura Kinsey, David French, Sacha Howell, et al.
Acta Oncologica (Stockholm, Sweden)|August 27, 2025
Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000Hannah Chamberlin, Georgios Ntentas, David J Cutter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Impaired tamoxifen metabolism reduces survival in familial breast cancer patientsWilliam G Newman, Kristen D Hadfield, Ayshe Latif, et al.
Breast (Edinburgh, Scotland)|February 26, 2019
Predictors of weight gain in a cohort of premenopausal early breast cancer patients receiving chemotherapyAshu Gandhi, Ellen Copson, Diana Eccles, et al.
Trials|January 17, 2020
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trialRob Coleman, Janet Brown, Emma Rathbone, et al.
Breast Cancer Research and Treatment|January 29, 2010
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancerRuth E Board, Andrew M Wardley, J Michael Dixon, et al.
British Journal of Cancer|August 2, 2019
The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trialMichelle Harvie, Mary Pegington, Debbie McMullan, et al.
Breast Cancer Research and Treatment|October 27, 2017
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Breast Cancer Research and Treatment|June 15, 2017
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patientsCarlo Palmieri, Rob C Stein, Xinxue Liu, et al.
Journal of Bone Oncology|July 8, 2022
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial resultsMatthew Winter, Rob Coleman, Jessica Kendall, et al.
Pageof 3